AbbVie
ABBV NYSE
Medicare add-on payments
- New
- 0
- Continued
- 1
- Lost
- 1
| Status | Technology | Max add-on payment | Implied cost per case |
|---|---|---|---|
| Continued | EMBLAVEO (aztreonam-avibactam) | $9,001 | $12,001 |
| Lost | EPKINLY (epcoritamab-bysp) and COLUMVI (glofitamab-gxbm) | $6,504prior-year maximum | $10,006 |
FDA device recalls, last 36 months
FDA data as of . Source: openFDA. FDA data may be out of date.
| Class | Product | Reason | Initiated | FDA record |
|---|---|---|---|---|
| Class II | Keller Funnel 2, REF: HA-001, STERILEEO, Rx Only, | Their is a potential that breast implants lack the lubricious coating that allows them to slide through the funnels during the implantation procedure. | Mar 14, 2024 | FDA record |